1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > North America Urinary Tract Stenting Procedures Outlook to 2020

North America Urinary Tract Stenting Procedures Outlook to 2020

Summary

GlobalData’s new report, "North America Urinary Tract Stenting Procedures Outlook to 2020", provides key market data on the North America Urinary Tract Stenting Procedures. The report provides procedure volumes within market segments - Ureteral Stenting Procedures (Unilateral and Bilateral Ureteral Stenting Procedures), Prostate Stenting Procedures (Procedures using Metal Stents, Polymer Stents and Bioabsorbable Stents) and Urethral Stenting Procedures (Procedures using Metal Stents, Polymer Stents and Bioabsorbable Stents).

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- Procedure volumes by segment - Ureteral Stenting Procedures (Unilateral and Bilateral Ureteral Stenting Procedures), Prostate Stenting Procedures (Procedures using Metal Stents, Polymer Stents and Bioabsorbable Stents) and Urethral Stenting Procedures (Procedures using Metal Stents, Polymer Stents and Bioabsorbable Stents).
- Projections for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

Table Of Contents

North America Urinary Tract Stenting Procedures Outlook to 2020
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Urinary Tract Stenting Procedures, Segmentation 5
2.3 Definitions of Procedures Covered in the Report 5
3 Urinary Tract Stenting Procedures, North America 7
3.1 Urinary Tract Stenting Procedures, North America, 2005-2020 7
3.2 Urinary Tract Stenting Procedures, North America, Category Comparison by Procedures, 2005-2020 9
3.3 Urinary Tract Stenting Procedures, North America, 2005-2013 10
3.4 Urinary Tract Stenting Procedures, North America, 2013-2020 12
4 Urinary Tract Stenting Procedures, Canada 14
4.1 Urinary Tract Stenting Procedures, Canada, 2005-2013 14
4.2 Urinary Tract Stenting Procedures, Canada, 2013-2020 16
4.2.1 Prostate Stenting Procedures, Canada, 2005-2013 18
4.2.2 Ureteral Stenting Procedures, Canada, 2005-2013 19
4.2.3 Urethral Stenting Procedures, Canada, 2005-2013 20
4.2.4 Prostate Stenting Procedures, Canada, 2013-2020 21
4.2.5 Ureteral Stenting Procedures, Canada, 2013-2020 22
4.2.6 Urethral Stenting Procedures, Canada, 2013-2020 23
5 Urinary Tract Stenting Procedures, Mexico 24
5.1 Urinary Tract Stenting Procedures, Mexico, 2005-2013 24
5.2 Urinary Tract Stenting Procedures, Mexico, 2013-2020 26
5.2.1 Prostate Stenting Procedures, Mexico, 2005-2013 28
5.2.2 Ureteral Stenting Procedures, Mexico, 2005-2013 29
5.2.3 Urethral Stenting Procedures, Mexico, 2005-2013 30
5.2.4 Prostate Stenting Procedures, Mexico, 2013-2020 31
5.2.5 Ureteral Stenting Procedures, Mexico, 2013-2020 32
5.2.6 Urethral Stenting Procedures, Mexico, 2013-2020 33
6 Urinary Tract Stenting Procedures, United States 34
6.1 Urinary Tract Stenting Procedures, United States, 2005-2013 34
6.2 Urinary Tract Stenting Procedures, United States, 2013-2020 36
6.2.1 Prostate Stenting Procedures, United States, 2005-2013 38
6.2.2 Ureteral Stenting Procedures, United States, 2005-2013 39
6.2.3 Urethral Stenting Procedures, United States, 2005-2013 41
6.2.4 Prostate Stenting Procedures, United States, 2013-2020 42
6.2.5 Ureteral Stenting Procedures, United States, 2013-2020 44
6.2.6 Urethral Stenting Procedures, United States, 2013-2020 45
7 Appendix 47
7.1 Research Methodology 48
7.1.1 Coverage 48
7.1.2 Secondary Research 48
7.1.3 Primary Research 49
7.1.4 Market Modeling and Forecasting 50
7.1.5 Company Share Analysis 53
7.1.6 Distribution Share Analysis 54
7.2 Expert Panel 54
7.3 GlobalData Consulting 55
7.4 Contact Us 55
7.5 Disclaimer 55

1.1 List of Tables
Table 1: Urinary Tract Stenting Procedures, North America, 2005-2020 8
Table 2: Urinary Tract Stenting Procedures, North America, Category Comparison by Procedures, 2005-2020 9
Table 3: Urinary Tract Stenting Procedures, North America, Historic, 2005-2013 11
Table 4: Urinary Tract Stenting Procedures, North America, Forecast, 2013-2020 13
Table 5: Urinary Tract Stenting Procedures, Canada, Historic, 2005-2013 15
Table 6: Urinary Tract Stenting Procedures, Canada, Forecast, 2013-2020 17
Table 7: Prostate Stenting Procedures, Canada, Historic, 2005-2013 18
Table 8: Ureteral Stenting Procedures, Canada, Historic, 2005-2013 19
Table 9: Urethral Stenting Procedures, Canada, Historic, 2005-2013 20
Table 10: Prostate Stenting Procedures, Canada, Forecast, 2013-2020 21
Table 11: Ureteral Stenting Procedures, Canada, Forecast, 2013-2020 22
Table 12: Urethral Stenting Procedures, Canada, Forecast, 2013-2020 23
Table 13: Urinary Tract Stenting Procedures, Mexico, Historic, 2005-2013 25
Table 14: Urinary Tract Stenting Procedures, Mexico, Forecast, 2013-2020 27
Table 15: Prostate Stenting Procedures, Mexico, Historic, 2005-2013 28
Table 16: Ureteral Stenting Procedures, Mexico, Historic, 2005-2013 29
Table 17: Urethral Stenting Procedures, Mexico, Historic, 2005-2013 30
Table 18: Prostate Stenting Procedures, Mexico, Forecast, 2013-2020 31
Table 19: Ureteral Stenting Procedures, Mexico, Forecast, 2013-2020 32
Table 20: Urethral Stenting Procedures, Mexico, Forecast, 2013-2020 33
Table 21: Urinary Tract Stenting Procedures, United States, Historic, 2005-2013 35
Table 22: Urinary Tract Stenting Procedures, United States, Forecast, 2013-2020 37
Table 23: Prostate Stenting Procedures, United States, Historic, 2005-2013 38
Table 24: Ureteral Stenting Procedures, United States, Historic, 2005-2013 40
Table 25: Urethral Stenting Procedures, United States, Historic, 2005-2013 41
Table 26: Prostate Stenting Procedures, United States, Forecast, 2013-2020 43
Table 27: Ureteral Stenting Procedures, United States, Forecast, 2013-2020 44
Table 28: Urethral Stenting Procedures, United States, Forecast, 2013-2020 46
Table 29: Total Number of Primary Research Participants, General Surgery Market, by Country 50

1.2 List of Figures
Figure 1: Urinary Tract Stenting Procedures, North America, 2005-2020 7
Figure 2: Urinary Tract Stenting Procedures, North America, Category Comparison by Procedures, 2005-2020 9
Figure 3: Urinary Tract Stenting Procedures, North America, Historic, 2005-2013 10
Figure 4: Urinary Tract Stenting Procedures, North America, Forecast, 2013-2020 12
Figure 5: Urinary Tract Stenting Procedures, Canada, Historic, 2005-2013 14
Figure 6: Urinary Tract Stenting Procedures, Canada, Forecast, 2013-2020 16
Figure 7: Prostate Stenting Procedures, Canada, Historic, 2005-2013 18
Figure 8: Ureteral Stenting Procedures, Canada, Historic, 2005-2013 19
Figure 9: Urethral Stenting Procedures, Canada, Historic, 2005-2013 20
Figure 10: Prostate Stenting Procedures, Canada, Forecast, 2013-2020 21
Figure 11: Ureteral Stenting Procedures, Canada, Forecast, 2013-2020 22
Figure 12: Urethral Stenting Procedures, Canada, Forecast, 2013-2020 23
Figure 13: Urinary Tract Stenting Procedures, Mexico, Historic, 2005-2013 24
Figure 14: Urinary Tract Stenting Procedures, Mexico, Forecast, 2013-2020 26
Figure 15: Prostate Stenting Procedures, Mexico, Historic, 2005-2013 28
Figure 16: Ureteral Stenting Procedures, Mexico, Historic, 2005-2013 29
Figure 17: Urethral Stenting Procedures, Mexico, Historic, 2005-2013 30
Figure 18: Prostate Stenting Procedures, Mexico, Forecast, 2013-2020 31
Figure 19: Ureteral Stenting Procedures, Mexico, Forecast, 2013-2020 32
Figure 20: Urethral Stenting Procedures, Mexico, Forecast, 2013-2020 33
Figure 21: Urinary Tract Stenting Procedures, United States, Historic, 2005-2013 34
Figure 22: Urinary Tract Stenting Procedures, United States, Forecast, 2013-2020 36
Figure 23: Prostate Stenting Procedures, United States, Historic, 2005-2013 38
Figure 24: Ureteral Stenting Procedures, United States, Historic, 2005-2013 39
Figure 25: Urethral Stenting Procedures, United States, Historic, 2005-2013 41
Figure 26: Prostate Stenting Procedures, United States, Forecast, 2013-2020 42
Figure 27: Ureteral Stenting Procedures, United States, Forecast, 2013-2020 44
Figure 28: Urethral Stenting Procedures, United States, Forecast, 2013-2020 45
Figure 29: GlobalData Epidemiology-Based Forecasting Model 52
Figure 30: GlobalData Capital Equipment-Based Forecasting Model 53
Figure 31: Primary Interviews by Participant Type (%) 54

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.